J. Meloche

发表

Krüppel-like Factor 5 contributes to pulmonary artery smooth muscle proliferation and resistance to apoptosis in human pulmonary arterial hypertension

S. Provencher, S. Bonnet, M. Barrier, 2011, Respiratory research.

PIM1 (Moloney Murine Leukemia Provirus Integration Site) Inhibition Decreases the Nonhomologous End-Joining DNA Damage Repair Signaling Pathway in Pulmonary Hypertension

È. Tremblay, F. Potus, S. Provencher, 2020, Arteriosclerosis, thrombosis, and vascular biology.

Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases.

S. Bonnet, D. Richard, J. Meloche, 2010, American journal of physiology. Heart and circulatory physiology.

Anti-inflammatory and immunosuppressive agents in PAH.

S. Provencher, S. Bonnet, J. Meloche, 2013, Handbook of experimental pharmacology.

Critical Role for the Advanced Glycation End‐Products Receptor in Pulmonary Arterial Hypertension Etiology

Y. Deshaies, S. Breuils-bonnet, È. Tremblay, 2013, Journal of the American Heart Association.

miR-223 reverses experimental pulmonary arterial hypertension.

F. Perros, S. Breuils-bonnet, È. Tremblay, 2015, American journal of physiology. Cell physiology.

Cell Signaling : Proteins , Pathways and Mechanisms miR-223 reverses experimental pulmonary arterial hypertension

F. Perros, S. Breuils-bonnet, È. Tremblay, 2015 .

Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension.

M. Humbert, E. Fadel, B. Girerd, 2016, American journal of respiratory and critical care medicine.

Longitudinal follow-up of the asthma status in a French–Canadian cohort

L. Boulet, C. Laprise, P. Bégin, 2022, Scientific reports.

Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.

S. Bonnet, R. Paulin, A. Courboulin, 2011, American journal of physiology. Heart and circulatory physiology.

, Audrey hypertensionconstitutive activation in pulmonary arterial Dehydroepiandrosterone inhibits the Src / STAT 3

S. Bonnet, R. Paulin, A. Courboulin, 2014 .

Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension

M. Humbert, E. Fadel, C. Péchoux, 2016, Circulation.

Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension

D. Altieri, S. Breuils-bonnet, È. Tremblay, 2018, American journal of respiratory and critical care medicine.

Signal transduction in the development of pulmonary arterial hypertension

F. Potus, S. Provencher, S. Bonnet, 2013, Pulmonary circulation.

Therapeutic Potential of microRNA Modulation in Pulmonary Arterial Hypertension.

S. Provencher, S. Bonnet, R. Paulin, 2015, Current vascular pharmacology.

STAT3 signaling in pulmonary arterial hypertension

S. Bonnet, R. Paulin, J. Meloche, 2012, JAK-STAT.

DNA Damage and Pulmonary Hypertension

S. Provencher, S. Bonnet, O. Boucherat, 2016, International journal of molecular sciences.

Role for DNA Damage Signaling in Pulmonary Arterial Hypertension

C. Couture, S. Breuils-bonnet, È. Tremblay, 2014, Circulation.

The Journal of Experimental Medicine CORRESPONDENCE

E. Paquet, S. Provencher, S. Bonnet, 2005 .

DNA damage at the dawn of micro-RNA pathway impairment in pulmonary arterial hypertension

F. Potus, S. Provencher, S. Bonnet, 2015 .

Implication of Inflammation and Epigenetic Readers in Coronary Artery Remodeling in Patients With Pulmonary Arterial Hypertension

S. Breuils-bonnet, È. Tremblay, F. Potus, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Bromodomain-Containing Protein 4Novelty and Significance

S. Breuils-bonnet, È. Tremblay, F. Potus, 2015 .

miRNAs in PAH: biomarker, therapeutic target or both?

S. Provencher, S. Bonnet, J. Meloche, 2014, Drug discovery today.

Altered Tissue Amino Acid Metabolism in Acute T-2 Toxicosis

T. Smith, J. Meloche, 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Targeting cell motility in pulmonary arterial hypertension

S. Provencher, S. Bonnet, E. Michelakis, 2013, European Respiratory Journal.

Asthma-associated polymorphisms in 17q12-21 locus modulate methylation and gene expression of GSDMA in naïve CD4+ T cells.

Warren A. Cheung, T. Pastinen, C. Laprise, 2020, Journal of genetics and genomics = Yi chuan xue bao.

GSDMA drives the most replicated association with asthma in naïve CD4+ T cells

Warren A. Cheung, T. Pastinen, C. Laprise, 2019, bioRxiv.

Bromodomain-Containing Protein 4: The Epigenetic Origin of Pulmonary Arterial Hypertension.

S. Breuils-bonnet, È. Tremblay, F. Potus, 2015, Circulation research.

RAGE-Dependent Activation of the Oncoprotein Pim1 Plays a Critical Role in Systemic Vascular Remodeling Processes

Mark A Sussman, S. Bonnet, M. Barrier, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Today’s and tomorrow’s imaging and circulating biomarkers for pulmonary arterial hypertension

S. Provencher, S. Bonnet, M. Barrier, 2012, Cellular and Molecular Life Sciences.

Signal Transducers and Activators of Transcription-3/Pim1 Axis Plays a Critical Role in the Pathogenesis of Human Pulmonary Arterial Hypertension

Mark A Sussman, S. Provencher, S. Bonnet, 2011, Circulation.

Adaptation and remodelling of the pulmonary circulation in pulmonary hypertension.

S. Bonnet, J. Meloche, G. Ruffenach, 2015, The Canadian journal of cardiology.

Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly

C. Laprise, J. Nadaf, J. Majewski, 2019, Molecular genetics & genomic medicine.

Role for DNA Damage Signaling in Pulmonary Arterial Hypertension

C. Couture, S. Breuils-bonnet, È. Tremblay, 2014, Circulation.

Role for miR-204 in human pulmonary arterial hypertension

E. Paquet, S. Provencher, S. Bonnet, 2011, The Journal of experimental medicine.

miR-223 reverses experimental pulmonary arterial hypertension.

F. Perros, S. Breuils-bonnet, È. Tremblay, 2015, American journal of physiology. Cell physiology.